(Q37690308)

22 August 2017

1 reference

title

Prognostic value and biological role of the kallikrein-related peptidases in human malignancies (English)

1 reference

22 August 2017

Konstantinos Mavridis

object named as

Konstantinos Mavridis

series ordinal

1

0 references

Andreas Scorilas

object named as

Andreas Scorilas

series ordinal

2

0 references

language of work or name

English

0 references

publication date

1 February 2010

1 reference

22 August 2017

1 reference

22 August 2017

6

1 reference

22 August 2017

269-285

1 reference

22 August 2017

2

1 reference

22 August 2017

Cancer statistics, 2009

1 reference

https://api.crossref.org/works/10.2217%2FFON.09.149

Emerging biomarkers for the diagnosis and prognosis of prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON.09.149

The footprints of cancer development: Cancer biomarkers

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON.09.149

Human tissue kallikreins: a new enzymatic cascade pathway?

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON.09.149

Genomic organization of the human kallikrein gene family on chromosome 19q13.3-q13.4.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON.09.149

Human tissue kallikreins: the cancer biomarker family

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON.09.149

Human tissue kallikrein gene family: applications in cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON.09.149

Human kallikrein 13 protein in ovarian cancer cytosols: a new favorable prognostic marker

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON.09.149

Human and mouse proteases: a comparative genomic approach

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON.09.149

The kallikrein world: an update on the human tissue kallikreins

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON.09.149

Impact of cytogenetic and genomic aberrations of the kallikrein locus in ovarian cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON.09.149

New insights into the functional mechanisms and clinical applications of the kallikrein-related peptidase family

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON.09.149

Kallikrein-related peptidases

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON.09.149

Localized prostate cancer: can we better define who is at risk of unfavourable outcome?

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON.09.149

Structure and chromosomal localization of the human renal kallikrein gene

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON.09.149

The new human tissue kallikrein gene family: structure, function, and association to disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON.09.149

Insulin-like growth factor 1 and prostate cancer risk: a population-based, case-control study

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON.09.149

hK2 and free PSA, a prognostic combination in predicting minimal prostate cancer in screen-detected men within the PSA range 4-10 ng/ml.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON.09.149

Prostate kallikrein markers in diagnosis, risk stratification and prognosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON.09.149

Prostate cancer diagnosis in the new millennium: strengths and weaknesses of prostate-specific antigen and the discovery and clinical evaluation of prostate cancer gene 3 (PCA3).

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON.09.149

The discovery of prostate specific antigen as a biomarker for the early detection of adenocarcinoma of the prostate.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON.09.149

The emerging roles of human tissue kallikreins in cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON.09.149

Kallikrein 4 is a proliferative factor that is overexpressed in prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON.09.149

Kallikrein 4 is a predominantly nuclear protein and is overexpressed in prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON.09.149

Kallikrein 4 (hK4) and prostate-specific antigen (PSA) are associated with the loss of E-cadherin and an epithelial-mesenchymal transition (EMT)-like effect in prostate cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON.09.149

Kallikrein 4 is a potential mediator of cellular interactions between cancer cells and osteoblasts in metastatic prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON.09.149

Substrates of the prostate-specific serine protease prostase/KLK4 defined by positional-scanning peptide libraries

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON.09.149

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON.09.149

Kallikrein 4 is associated with paclitaxel resistance in ovarian cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON.09.149

Biochemical and enzymatic characterization of human kallikrein 5 (hK5), a novel serine protease potentially involved in cancer progression

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON.09.149

Parallel underexpression of kallikrein 5 and kallikrein 7 mRNA in breast malignancies.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON.09.149

Human kallikrein gene 5 (KLK5) expression is an indicator of poor prognosis in ovarian cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON.09.149

Immunofluorometric quantification of human kallikrein 5 expression in ovarian cancer cytosols and its association with unfavorable patient prognosis

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON.09.149

Prediction of ovarian cancer prognosis and response to chemotherapy by a serum-based multiparametric biomarker panel.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON.09.149

Association of KLK5 overexpression with invasiveness of urinary bladder carcinoma cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON.09.149

Down-regulation of the human kallikrein gene 5 (KLK5) in prostate cancer tissues

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON.09.149

Quantitative analysis of human kallikrein 5 (KLK5) expression in prostate needle biopsies: an independent cancer biomarker.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON.09.149

Differential expression of Kallikrein gene 5 in cancerous and normal testicular tissues

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON.09.149

The use of kallikrein-related peptidases as adjuvant prognostic markers in colorectal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON.09.149

Increased expression of protease M in ovarian tumors.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON.09.149

Immunofluorometric quantitation and histochemical localisation of kallikrein 6 protein in ovarian cancer tissue: a new independent unfavourable prognostic biomarker

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON.09.149

Transcriptional upregulation of human tissue kallikrein 6 in ovarian cancer: clinical and mechanistic aspects.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON.09.149

Prognostic value of kallikrein-related peptidase 6 protein expression levels in advanced ovarian cancer evaluated by automated quantitative analysis (AQUA).

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON.09.149

KLK6 and KLK13 predict tumor recurrence in epithelial ovarian carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON.09.149

Differential N-glycosylation of kallikrein 6 derived from ovarian cancer cells or the central nervous system

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON.09.149

Clinical significance of human kallikrein gene 6 messenger RNA expression in colorectal cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON.09.149

Clinicopathologic and biological significance of kallikrein 6 overexpression in human gastric cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON.09.149

Kallikrein 6 is a mediator of K-RAS-dependent migration of colon carcinoma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON.09.149

Human kallikrein 6: a new potential serum biomarker for uterine serous papillary cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON.09.149

Co-expression of KLK6 and KLK10 as prognostic factors for survival in pancreatic ductal adenocarcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON.09.149

Prognostic implications of the immunohistochemical expression of human kallikreins 5, 6, 10 and 11 in renal cell carcinoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON.09.149

A tumor-protective role for human kallikrein-related peptidase 6 in breast cancer mediated by inhibition of epithelial-to-mesenchymal transition

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON.09.149

The KLK7 (PRSS6) gene, encoding for the stratum corneum chymotryptic enzyme is a new member of the human kallikrein gene family - genomic characterization, mapping, tissue expression and hormonal regulation

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON.09.149

Human tissue kallikrein 7, a novel biomarker for advanced ovarian carcinoma using a novel in situ quantitative method of protein expression

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON.09.149

Kallikrein 7 enhances pancreatic cancer cell invasion by shedding E-cadherin

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON.09.149

The serine protease stratum corneum chymotryptic enzyme (kallikrein 7) is highly overexpressed in squamous cervical cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON.09.149

Ontogeny of neuropsin mRNA expression in the mouse brain.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON.09.149

Sequence analysis and expression of human neuropsin cDNA and gene.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON.09.149

Human kallikrein 8 protein is a favorable prognostic marker in ovarian cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON.09.149

Human kallikrein 8 protease confers a favorable clinical outcome in non-small cell lung cancer by suppressing tumor cell invasiveness

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON.09.149

The expanded human kallikrein gene family: locus characterization and molecular cloning of a new member, KLK-L3 (KLK9).

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON.09.149

Distribution of 15 human kallikreins in tissues and biological fluids.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON.09.149

The prognostic value of the human kallikrein gene 9 (KLK9) in breast cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON.09.149

Loss of expression of the putative tumor suppressor NES1 gene in biopsy-proven ductal carcinoma in situ predicts for invasive carcinoma at definitive surgery

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON.09.149

Kallikrein 10 (KLK10) methylation as a novel prognostic biomarker in early breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON.09.149

Higher expression of human kallikrein 10 in breast cancer tissue predicts tamoxifen resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON.09.149

Identification of single nucleotide polymorphisms in the human kallikrein 10 (KLK10) gene and their association with prostate, breast, testicular, and ovarian cancers

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON.09.149

Expression of the normal epithelial cell-specific 1 (NES1; KLK10) candidate tumour suppressor gene in normal and malignant testicular tissue

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON.09.149

Genomic organization, mapping, tissue expression, and hormonal regulation of trypsin-like serine protease (TLSP PRSS20), a new member of the human kallikrein gene family

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON.09.149

Human kallikrein gene 11 (KLK11) mRNA overexpression is associated with poor prognosis in patients with epithelial ovarian cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON.09.149

Favorable prognostic value of tissue human kallikrein 11 (hK11) in patients with ovarian carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON.09.149

Human kallikrein 11: an indicator of favorable prognosis in ovarian cancer patients

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON.09.149

Quantitative analysis of hippostasin/KLK11 gene expression in cancerous and noncancerous prostatic tissues

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON.09.149

Expression analysis and prognostic significance of human kallikrein 11 in prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON.09.149

Decreased kallikrein 11 messenger RNA expression in lung cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON.09.149

KLK12 is a novel serine protease and a new member of the human kallikrein gene family-differential expression in breast cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON.09.149

A multiparametric serum kallikrein panel for diagnosis of non-small cell lung carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON.09.149

Identification and characterization of KLK-L4, a new kallikrein-like gene that appears to be down-regulated in breast cancer tissues

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON.09.149

Human kallikrein gene 13 (KLK13) expression by quantitative RT-PCR: an independent indicator of favourable prognosis in breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON.09.149

Human kallikrein 13 involvement in extracellular matrix degradation

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON.09.149

Quantitative RT-PCR analysis and immunohistochemical localization of the kallikrein-related peptidases 13 and 14 in lung

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON.09.149

Expression and functional characterization of the cancer-related serine protease, human tissue kallikrein 14

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON.09.149

Activation of proteinase-activated receptor-2 by human kallikrein-related peptidases.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON.09.149

Quantitative analysis of human kallikrein gene 14 expression in breast tumours indicates association with poor prognosis

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON.09.149

Expression of human Kallikrein 14 (KLK14) in breast cancer is associated with higher tumour grades and positive nodal status

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON.09.149

Differential expression of the human kallikrein gene 14 (KLK14) in normal and cancerous prostatic tissues

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON.09.149

High expression of KLK14 in prostatic adenocarcinoma is associated with elevated risk of prostate-specific antigen relapse

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON.09.149

Molecular cloning of the human kallikrein 15 gene (KLK15). Up-regulation in prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON.09.149

Quantitative analysis of kallikrein 15 gene expression in prostate tissue

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON.09.149

Activation of prostate-specific antigen precursor (pro-PSA) by prostin, a novel human prostatic serine protease identified by degenerate PCR

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON.09.149

Prognostic value of the human kallikrein gene 15 expression in ovarian cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON.09.149

The androgen-regulated gene human kallikrein 15 (KLK15) is an independent and favourable prognostic marker for breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON.09.149

microRNAs: a new frontier in kallikrein research

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON.09.149

Functional roles of human kallikrein-related peptidases

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON.09.149

Comparison of Free and Total Forms of Serum Human Kallikrein 2 and Prostate-Specific Antigen for Prediction of Locally Advanced and Recurrent Prostate Cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON.09.149

Human tissue kallikreins: from gene structure to function and clinical applications

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON.09.149

Serum human glandular kallikrein 2 (hK2) for distinguishing stage and grade of prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON.09.149

Human kallikrein 6 (zyme/protease M/neurosin): a new serum biomarker of ovarian carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON.09.149

Human Kallikrein 6 (hK6): A New Potential Serum Biomarker for Diagnosis and Prognosis of Ovarian Carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON.09.149

Prognostic value of quantitatively assessed KLK7 expression in ovarian cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON.09.149

Unfavorable Prognostic Value of Human Kallikrein 7 Quantified by ELISA in Ovarian Cancer Cytosols

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON.09.149

A Multiparametric Panel for Ovarian Cancer Diagnosis, Prognosis, and Response to Chemotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON.09.149

21 January 2018

Identifiers

DOI

10.2217/FON.09.149

1 reference

22 August 2017

1 reference

PubMed ID

20146586